New Therapy for HIV Patients with Advanced Disease (Oct '05)

FDA recently approved a new drug for patients with advanced HIV disease. The drug, called Aptivus (tipranavir) is an HIV protease inhibitor. It's intended to be given in combination with ritonavir and other antiretroviral drugs to patients who have limited treatment options. Aptivus is made by Boehringer Ingelheim Pharmaceuticals.

In clinical trials, Aptivus, when used in combination with ritonavir and other antiretroviral agents, was shown to be effective in patients who had HIV strains highly resistant to other drugs.

The product labeling will carry a boxed warning that Aptivus can cause serious liver problems, especially in patients with liver disease. Because of the potential for serious drug interactions, certain drugs are contraindicated in patients taking Aptivus plus ritonavir. They include certain antiarrhythmics, antihistamines, ergot derivatives and herbal products.

Category:

News & Politics

Tags:

• Therapy
• HIV
• Patients
• Advanced
• Disease
• Aptivus
• (tipranavir)
• Protease
• Inhibitor
• Antiretroviral
• Drugs
• FDA
• Liver
• Probelms

[UDAY704]

thats true..and the best way for prevention of HIV is awarness and also to make people aware about the disease

[hivquestions]

the leading cause of death for those diagnosed with AIDS is organ failure due to toxic hiv medications. the micrographs of hiv are fraudulent. the hiv test is cross-reactive and pregnancy and drug use can cause false positives. there is no scientific proof to link hiv with the syndrome AIDS. the hiv test only tests for proteins and not for actual virus. please pray for all those affected.